Als Kongresspräsident lud Professor Stefan N. Willich von der Berliner Charité zur Diskussion über die Möglichkeit, dem Wunsch der Patienten nach integrierter medizinischer Versorgung nachzukommen. Denn bei chronischen oder Herz-Kreislauf-Erkrankungen zum Beispiel möchten die Menschen sowohl schulmedizinische Aufklärung und Behandlung durch ihren Arzt als auch…
The Swiss charity EurAsia Heart, founded in 2006 by cardiac surgeon Professor Paul Vogt MD, at Zurich University Hospital, emerged from numerous contacts being made with Asian heart surgeons at the beginning of 2000, and consequent invitations to perform surgery and lecture tours in China.
Dynamic mattresses, also called alternating air pressure mattresses or replacement mattress systems, have air cells that alternately inflate and deflate in a cycle to relieve pressure on the body.
Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.
27 EU countries were represented in at least one of the eight short-listed entries for this award.
Currently, early detection of Prostate Cancer depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses. The prostate-cancer-gene-3 (PCA3) test is a new PCa gene-based marker carried out with a urine sample.
Tumour ablation - and Radiofrequency (RF) ablation in particular - is getting more and more important in oncology. The therapy option offers benefits in terms of costs, ease of set-up and flexibility so that experts see the need to expand the applications of it.
The number 1 fair for people with special needs, those requiring care and the chronically ill the REHACARE 2008, takes place from 15 to 18 October, Halls 3 to 7 of the Düsseldorf Trade Fair.The event will host 800 exhibitors from 30 countries presenting assistive devices and services to facilitate independent living.
Bis zu 92 Prozent der so Behandelten erleben eine deutliche Beschwerden-Linderung durch die rückenmarksnahe Applizierung von Baclofen mittels einer implantierten Pumpe von Medtronic.
The UK's National Health Service is notorious for its waiting time for surgery. The Scottish Government recently decided to tackle this issue and proposed a Patient Rights Bill which includes a legal right to surgery within twelve weeks .
A hearing test screening, designed to detect hearing impairments in newborns, shell help prevent irreversible and permanent hearing problems in about 2000 babies in Germany per year. From 1 January 2009, this test might be covered by the statutory health insurances
Researchers have discovered a potential new treatment for diabetes by isolating and killing defective cells which prevent the natural production of insulin. The investigation opens the door to a potential therapy for patients with type 1 diabetes.
Bayer HealthCare Diabetes Care unveiled the new CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
According to a study conducted by researchers at the University of Zurich and the Zurich University Hospital the answer is: Yes. They demonstrated that one injection per month sufficed to improve blood sugar levels significantly. Even more: The insulin production of the patients improved.
Transition Therapeutics Inc. announced that the first patient has been dosed in a Phase 2 clinical study of gastrin analogue, TT-223, in patients with type 2 diabetes. Gastrin based therapies are an emerging class of potential disease-modifying treatments for patients with diabetes.
Researchers at Linköping University and Uppsala University in Sweden can show that accumulation of protein aggregatess, amyloid, in the transplanted cells may be causing their death. With the aid of their results, physicians can enhance survival of islets transplants and improve treatment of type 1 diabetes.
The German Federal Ministry of Education and Research recently agreed funding for a diabetes competence network — the first diabetes mellitus project to be funded by the ministry's new “Health Research — Research for People” programme.
Approximately 31 million people in the European Union are suffering from diabetes, a devastating disease with severe consequences for patients and their families, but also for the society at large and the economic prosperity of Europe. This week EH Online will focus on innovative strategies in diabetes care and on new management systems to support physicians and patients alike. Moreover, we will…
ESC speaker John Cleland from the University of Hull, UK, sumed up the latest treatment available for patients with diabetes mellitus and expressed his worries about side-effects and efficacy of available anti-diabetic drugs. If you want to read his ESC abstract, just click the “read more” button.
French findings support the notion that gastric bypass can rapidly reverse diabetes symptoms' a side-effect that lap-band surgery does not show. The benefit results from a new-found element of glucose production by the intestine which also increases insulin sensitivity and lowers blood sugar.
A new analysis presented during the ESC on the effects of cardiac resynchronization therapy (CRT) in patients with mild heart failure shows improvement in several areas, including left ventricular ejection fraction, a standard measure of the heart's pumping effectiveness and key indicator of heart health.
"Surgery should be performed using as often as possible surgical mitral valve repair, as this treatment has shown safety, efficacy and good long-term results," says French Prof Alec Vahanian on Monday, the third ESC day.
Royal Philips Electronics is to lead `euHeart´, the new European Union (EU) funded research project that aims to improve CVD diagnosis, therapy planning and treatment.
Seeking to set the agenda for urgent atrial fibrillation (AF) research, European and international cardiologists will gather this October at the European Heart House, in Sophia Antipolis, the headquarters of the European Society of Cardiology.
The ageing population and growing risk factors have made a significant impact on driving up the number of registered heart failure (HF) cases. Existing pharmacological strategies are improving the survival rates of acute and early-stage HF patients, ironically providing a growing body of patients with progression of the disease to HF.
